These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 38805166)

  • 1. Effects of Phytochemicals on Type 2 Diabetes via MicroRNAs.
    Sivri D; Gezmen-Karadağ M
    Curr Nutr Rep; 2024 Sep; 13(3):444-454. PubMed ID: 38805166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of glucose metabolism by bioactive phytochemicals for the management of type 2 diabetes mellitus.
    Zhao C; Yang C; Wai STC; Zhang Y; P Portillo M; Paoli P; Wu Y; San Cheang W; Liu B; Carpéné C; Xiao J; Cao H
    Crit Rev Food Sci Nutr; 2019; 59(6):830-847. PubMed ID: 30501400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of MicroRNAs by Phytochemicals: A Promising Strategy for Cancer Chemoprevention.
    Babashah S; Bakhshinejad B; Birgani MT; Pakravan K; Cho WC
    Curr Cancer Drug Targets; 2018; 18(7):640-651. PubMed ID: 28669335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective effects of flavonoids and carotenoids against diabetic complications-A review of
    Jin Y; Arroo R
    Front Nutr; 2023; 10():1020950. PubMed ID: 37032781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytochemical Regulation of RNA in Treating Inflammatory Bowel Disease and Colon Cancer: Inspirations from Cell and Animal Studies.
    Zhang G; Zhang C; Sun J; Xiong Y; Wang L; Chen D
    J Pharmacol Exp Ther; 2021 Mar; 376(3):464-472. PubMed ID: 33397676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of microRNAs in the Development of Type 2 Diabetes Complications.
    Paschou SA; Siasos G; Katsiki N; Tentolouris N; Tousoulis D
    Curr Pharm Des; 2020; 26(46):5969-5979. PubMed ID: 33138753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytochemicals mediated modulation of microRNAs and long non-coding RNAs in cancer prevention and therapy.
    Ruiz-Manriquez LM; Estrada-Meza C; Benavides-Aguilar JA; Ledesma-Pacheco SJ; Torres-Copado A; Serrano-Cano FI; Bandyopadhyay A; Pathak S; Chakraborty S; Srivastava A; Sharma A; Paul S
    Phytother Res; 2022 Feb; 36(2):705-729. PubMed ID: 34932245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals.
    Son SW; Lee HY; Moeng S; Kuh HJ; Choi SY; Park JK
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNAs in the Beta Cell-Friends or Foes?
    Karagiannopoulos A; Cowan E; Eliasson L
    Endocrinology; 2023 Mar; 164(5):. PubMed ID: 36869830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs: Novel Players in the Dialogue between Pancreatic Islets and Immune System in Autoimmune Diabetes.
    Ventriglia G; Nigi L; Sebastiani G; Dotta F
    Biomed Res Int; 2015; 2015():749734. PubMed ID: 26339637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of MicroRNAs in Diabetes and Its Complications.
    Wu B; Miller D
    Methods Mol Biol; 2017; 1617():225-239. PubMed ID: 28540689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-diabetic effect of hydroxybenzoic acid derivatives in free fatty acid-induced HepG2 cells via miR-1271/IRS1/PI3K/AKT/FOXO1 pathway.
    Lee H; Lee J
    J Food Biochem; 2021 Dec; 45(12):e13993. PubMed ID: 34730253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-Mediated Health-Promoting Effects of Phytochemicals.
    Kang H
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of microRNAs in diabetes mellitus.
    Chen H; Lan HY; Roukos DH; Cho WC
    J Endocrinol; 2014 Jul; 222(1):R1-R10. PubMed ID: 24781254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications.
    Hashiesh HM; Meeran MFN; Sharma C; Sadek B; Kaabi JA; Ojha SK
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32998300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes.
    Nesca V; Guay C; Jacovetti C; Menoud V; Peyot ML; Laybutt DR; Prentki M; Regazzi R
    Diabetologia; 2013 Oct; 56(10):2203-12. PubMed ID: 23842730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs and Cardiovascular Disease in Diabetes Mellitus.
    Ding Y; Sun X; Shan PF
    Biomed Res Int; 2017; 2017():4080364. PubMed ID: 28299324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs as therapeutic targets for the treatment of diabetes mellitus and its complications.
    Regazzi R
    Expert Opin Ther Targets; 2018 Feb; 22(2):153-160. PubMed ID: 29257914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.